Search

UT Southwestern Medical Center is ranked No. 1 among healthcare institutions worldwide by Nature Index for publishing high-quality research in all subjects for the 12-month period that ended Feb. 28, 2026.

Clinical exams that incorporate gait analysis after physical exertion may provide insight into how youths are recovering after concussions to help determine whether they are ready to return to sports, UT Southwestern Medical Center and Scottish Rite for Children (SRC) physicians found.

The outbreak of measles that started in West Texas in January and spread to other regions and states has focused renewed attention on a childhood disease that had been eliminated in the United States in recent decades.

The University of Texas Southwestern Medical Center and Parkland Health are consulting the people of the Dallas area on participating in a trauma research study to investigate using one dose of fresh frozen plasma (FFP), the colorless fluid part of blood, to treat patients who suffered a traumatic brain injury.

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug.

Researchers at UT Southwestern Medical Center have developed a computational method that reveals how immune cells navigate the complex environment inside tumors, offering insights that could inform future cancer therapies.

Scientists at UT Southwestern Medical Center, working with other U.S. researchers, have uncovered the structure of a key cell membrane protein in a bacterial model for Chlamydia trachomatis, the cause of the world’s most common bacterial sexually transmitted infection (STI).

Patients with cutaneous lupus erythematosus (CLE), an autoimmune disease that causes skin inflammation, have a higher risk for atherosclerotic cardiovascular disease (ASCVD), or hardening of the arteries, UT Southwestern Medical Center researchers found.

Oncology programs have sought to decrease visits by cancer patients to a hospital emergency department (ED) by offering resources such as 24/7 phone triage lines and urgent care clinics. However, these tend to be underutilized.

UT Southwestern Medical Center researchers identified a genetic mutation that slows the growth of melanoma and potentially other cancers by harnessing the power of the immune system. Their findings, published in the Journal of Experimental Medicine, could lead to new treatments that improve outcomes from existing cancer immunotherapies.